Notable Recent Publications

These are some recent publications which give a flavour of the research from the Barclay lab. For a complete list of publications, please see below.

Species difference in ANP32A underlies influenza A virus polymerase host restriction. Nature (2016).
Jason S. Long, Efstathios S. Giotis, Olivier Moncorgé, Rebecca Frise, Bhakti Mistry, Joe James, Mireille Morisson, Munir Iqbal, Alain Vignal, Michael A. Skinner & Wendy S. Barclay

This paper identified a key factor that explained why the polymerases from avian influenza viruses are restricted in humans.  For more, please see the associated New and Views.

See our latest ANP32 papers here: eLIFE, Journal of Virology, Journal of Virology.

The mechanism of resistance to favipiravir in influenza. PNAS (2018).
Daniel H. Goldhill, Aartjan J. W. te Velthuis, Robert A. Fletcher, Pinky Langat, Maria Zambon, Angie Lackenby & Wendy S. Barclay

This paper showed how influenza could evolve resistance to favipiravir, an antiviral that may be used to treat influenza. The residue that mutated to give resistance was highly conserved suggesting that the mechanism of resistance may be applicable to other RNA viruses.

Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. Plos Path. (2018).
Hui Li*, Konrad C. Bradley*, Jason S. Long, Rebecca Frise, Jonathan W. Ashcroft, Lorian C. Hartgroves, Holly Shelton, Spyridon Makris, Cecilia Johansson, Bin Cao & Wendy S. Barclay

Why do avian influenza viruses like H5N1 cause such severe disease in humans? This paper demonstrated that H5N1 viruses replicate better than human viruses in myeloid cells from mice leading to a cytokine storm and more severe disease.

Citation

BibTex format

@article{Koudstaal:2009:10.1016/j.vaccine.2009.02.033,
author = {Koudstaal, W and Hartgroves, L and Havenga, M and Legastelois, I and Ophorst, C and Sieuwerts, M and Zuijdgeest, D and Vogels, R and Custers, J and de, Boer-Luijtze E and de, Leeuw O and Cornelissen, L and Goudsmit, J and Barclay, W},
doi = {10.1016/j.vaccine.2009.02.033},
journal = {VACCINE},
pages = {2588--2593},
title = {Suitability of PER.C6® cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics},
url = {http://dx.doi.org/10.1016/j.vaccine.2009.02.033},
volume = {27},
year = {2009}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Koudstaal,W
AU  - Hartgroves,L
AU  - Havenga,M
AU  - Legastelois,I
AU  - Ophorst,C
AU  - Sieuwerts,M
AU  - Zuijdgeest,D
AU  - Vogels,R
AU  - Custers,J
AU  - de,Boer-Luijtze E
AU  - de,Leeuw O
AU  - Cornelissen,L
AU  - Goudsmit,J
AU  - Barclay,W
DO  - 10.1016/j.vaccine.2009.02.033
EP  - 2593
PY  - 2009///
SN  - 0264-410X
SP  - 2588
TI  - Suitability of PER.C6® cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics
T2  - VACCINE
UR  - http://dx.doi.org/10.1016/j.vaccine.2009.02.033
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000265735400012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 27
ER  -
Download

Contact us

For any enquiries related to this group, please contact:

Professor Wendy Barclay
Chair in Influenza Virology 
+44 (020) 7594 5035
w.barclay@imperial.ac.uk